Abstract
Normal cells secrete heat shock protein 90 alpha (Hsp90α) in response to tissue injury. Tumor cells have managed to constitutively secrete Hsp90α during invasion and metastasis. The sole function of extracellular Hsp90α (eHsp90α) is to promote cell motility, a critical event for both wound healing and tumor progression. The mechanism of promotility action by eHsp90α, however, has remained elusive. A key issue is whether eHsp90α still acts as a chaperone outside the cells or is a new and bona fide signaling molecule. Here, we have provided evidence that eHsp90α utilizes a unique transmembrane signaling mechanism to promote cell motility and wound healing. First, subdomain II in the extracellular part of low-density lipoprotein receptor-related protein 1 (LRP-1) receives the eHsp90α signal. Then, the NPVY but not the NPTY motif in the cytoplasmic tail of LRP-1 connects eHsp90α signaling to serine 473 but not threonine 308 phosphorylation in Akt kinases. Individual knockdown of Akt1, Akt2, or Akt3 revealed the importance of Akt1 and Akt2 in eHsp90α-induced cell motility. Akt gene rescue experiments suggest that Akt1 and Akt2 work in concert, rather than independently, to mediate eHsp90α promotility signaling. Finally, Akt1 and Akt2 knockout mice showed impaired wound healing that cannot be corrected by topical application with the eHsp90α protein.
Highlights
Normal cells secrete heat shock protein 90 alpha (Hsp90␣) in response to tissue injury
At least one physiological role for eHsp90␣ is promotion of tissue repair, such as skin wound healing [6, 9, 10]. Certain tumor cells, such as those that maintain a steady-state level of hypoxia-inducible factor 1 alpha (HIF-1␣), acquired the ability to constitutively secrete Hsp90␣ for invasion and metastasis [5, 6, 8, 11,12,13,14]
To investigate the mechanism of eHsp90␣ action, we focused on lipoprotein receptor-related protein 1 (LRP-1), a suggested cell surface receptor for eHsp90␣ signaling [20, 21]
Summary
Normal cells secrete heat shock protein 90 alpha (Hsp90␣) in response to tissue injury. EHsp90␣ promotes motility of all types of skin cells, overrides the inhibition of TGF3, and remains fully functional even under hyperglycemia In accordance with these in vitro features of eHsp90␣, topical application of recombinant Hsp90␣ accelerated wound healing with an efficacy significantly stronger than that of becaplermin (PDGFBB) gel [9]. We have established a novel eHsp90␣ cross-membrane signaling pathway that includes extracellular subdomain II and the cytoplasmic NPVY motif in the LRP-1 receptor and downstream activation of the Akt and Akt kinases. This pathway is essential for eHsp90␣-stimulated skin cell migration in vitro and wound healing in vivo
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.